The FDA is expanding a recall of a popular blood pressure drug over concern it may contain an unwanted ingredient that can cause cancer. Aurobindo Pharma says it is voluntarily recalling tablets with the ingredient valsartan because it found trace amounts of a substance known as NDEA. Recalls of contaminated valsartan products started in July and involve seven different companies. Dr. Tara Narula joins "CBS This Morning" with more on the latest recall.

Advertisement
Start a season-long league with your friends. Play for a share of $1,000,000. Get a free entry into the NFL Sunday Million with your first deposit. Payable Action: Deposit (Minimum $10) Restrictions: No incent. State restricted (see offer targeting).

More videos

France 24 22 Apr 2019 14:54 CEST

'Easter Sunday Terror'